Module

Treatment of Melanoma: Current Best Practice

Source: Melanoma Treatment Update

Treatment of Melanoma: Current Best Practice

Program Director: John M. Kirkwood, MD

Faculty:

Sanjiv S. Agarwala, MD

CME CREDIT INFORMATION

Release Date: 02/26/08

Expiration Date: 02/25/09

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe current recommended clinical practice for excision of localized melanomas and patient selection for sentinel lymph node biopsy
Discuss current evidence regarding the efficacy of interferon alfa adjuvant therapy in preventing relapse and extending survival in patients with high-risk melanoma
Summarize data on the efficacy of chemoimmunotherapy in patients with advanced melanoma
Identify novel agents for systemic therapy of melanoma currently being evaluated in clinical trials

Topics covered include:

Introduction
Treatment of Localized Melanoma
Adjuvant Therapy: Uncertain Benefits
Advanced Melanoma: Considering the Options in the Absence of Consensus
Systemic Therapy for Advanced Melanoma: Current Clinical Investigation
Conclusions

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.